Movement Alert|THE CIGNA GROUP Falls 3.46% in Regular Trading, Jefferies Downgrades to Hold

Market Focus08-05 21:41

On August 5, THE CIGNA GROUP fell 3.46% in regular trading, trading at approximately $270.97/share, with turnover of $61.59 million. The decline was triggered by Jefferies downgrading the stock from Buy to Hold, cutting its price target from $336 to $307, citing increasing earnings headwinds and a lack of clear catalysts.

This marks the second consecutive session of analyst downgrades. On August 4, Raymond James lowered its rating from Strong Buy to Outperform and reduced the target from $350 to $320, pointing to slowing business growth and persistent headwinds in the pharmacy benefit management segment. Both firms noted that while Q2 earnings beat estimates with adjusted EPS of $7.78 versus the $7.60 consensus, management confirmed during the earnings call that GLP-1 prescription growth is moderating, pressuring pharmacy operations.

The broader Health Care Services sector was under significant pressure, with CVS Health down 6.57% and DaVita HealthCare Partners down 17.54%, reflecting widespread weakness across managed care and health services names.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment